RPCEC00000312招募中未知
Homeoprophylaxis safety study with PrevengHo®-Vir in the context of the COVID-19 pandemic in Cuba. Quasi-experimental study post-registration (COVID-19) - PREVENGHO-COVID
Department of Natural and Traditional Medicine, Ministry of Public Health, Republic of Cuba0 个研究点目标入组 180 人开始时间: 2020年5月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 years 至 64 years（—）
- 性别
- All
入选标准
- •1. Individuals between 18 and 64 years of age.
- •2. Individuals without any respiratory symptoms at the time of administration of PrevengHo®-Vir.
排除标准
- •1. Individuals allergic to any of the components of the homeopathic medicine.
研究者
相似试验
进行中（未招募）
3 期
Study on the effects of using ivermectin to prevent COVID-19 in an adult population in BrazilPrevention of COVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN90437126Federal University of Pernambuco800
招募中
1 期
Safety evaluation of the preemptive immune-cell therapy against cancer.JPRN-jRCTc030230349Goto Shigenori650
招募中
1 期
Safety evaluation of the preemptive immune-cell therapy against cancer.JPRN-jRCTc030190261Goto Shigenori650
已完成
不适用
Comparison of Pregabalin and Sodium Valproate on prophylaxis of migraine type headacheMigraineIRCT2012070310178N1Shahid Beheshti University of Medical Sciences100
招募中
1 期
Phase I non-randomised safety study of prophylactic topical dexamethasone/hyaluronic acid formulation on facial nerves during parotidectomy and neck dissection surgeryParotid cancerNeck cancerParotidectomyNeck dissection surgeryACTRN12618000077268IntraVital Pty Ltd30